RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+52.23%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$3.55B
AUM Growth
+$3.55B
(+53%)
Cap. Flow
+$461M
Cap. Flow
% of AUM
12.97%
Top 10 Holdings %
Top 10 Hldgs %
48.38%
Holding
82
New
17
Increased
31
Reduced
8
Closed
5
Top Buys
| 1 |
Avidity Biosciences
RNA
|
$104M |
| 2 |
Baxter International
BAX
|
$83.5M |
| 3 |
CERN
Cerner Corp
CERN
|
$81.1M |
| 4 |
Axsome Therapeutics
AXSM
|
$49.8M |
| 5 |
10x Genomics
TXG
|
$39.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$94M |
| 2 |
Zimmer Biomet
ZBH
|
$67.9M |
| 3 |
Sarepta Therapeutics
SRPT
|
$51.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$36.8M |
| 5 |
STAAR Surgical
STAA
|
$22.6M |
Sector Composition
| 1 | Healthcare | 91.43% |
| 2 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
76
DELISTED
ViewRay, Inc.
VRAY
| $336K | 0.01% |
150,000
| – | – |
|
|
PHGE.WS
77
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
| $287K | 0.01% |
600,000
| – | – |
|
|
78
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-1,685,934
| Closed | -$94M |
|
|
79
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-529,261
| Closed | -$51.8M |
|
|
80
Zimmer Biomet
ZBH
$20.8B
| – | – |
-691,601
| Closed | -$67.9M |
|
|
GBT
81
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-719,489
| Closed | -$36.8M |
|